Financhill
Sell
49

ARCB Quote, Financials, Valuation and Earnings

Last price:
$77.07
Seasonality move :
-0.56%
Day range:
$76.49 - $77.85
52-week range:
$55.19 - $103.63
Dividend yield:
0.62%
P/E ratio:
18.29x
P/S ratio:
0.44x
P/B ratio:
1.31x
Volume:
198.7K
Avg. volume:
404.1K
1-year change:
-18.73%
Market cap:
$1.7B
Revenue:
$4.2B
EPS (TTM):
$4.21

Earnings Data

Next earnings date for ARCB
Jan 30
2026
Most recent earnings per share
$1.72
Beat by $0.35
(Nov 5/2025)
Consensus Estimate
$1.37
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARCB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/30/2026 Q4 $963.7M -- -- $0.41 --
11/05/2025 Q3 $1B $1B $1.72 $1.37 $0.35
07/30/2025 Q2 $1B $1B $1.12 $1.46 -$0.34
04/29/2025 Q1 $986.1M $967.1M $0.13 $0.52 -$0.38
01/31/2025 Q4 $995M $1B $1.24 $1.05 $0.19
11/01/2024 Q3 $1.1B $1.1B $4.23 $1.85 $2.38
08/02/2024 Q2 $1.1B $1.1B $1.96 $2.06 -$0.10
04/30/2024 Q1 $1B $1B -$0.13 $1.53 -$1.66
02/06/2024 Q4 $1.1B $1.1B $2.01 $2.23 -$0.21
10/27/2023 Q3 -- $1.1B $1.42 -- --
07/28/2023 Q2 -- $1.1B $1.59 -- --
04/28/2023 Q1 -- $1.1B $0.09 -- --
02/03/2023 Q4 -- $1.2B $1.48 -- --
11/01/2022 Q3 -- $1.3B $3.50 -- --
07/29/2022 Q2 -- $1.3B $4.00 -- --
04/29/2022 Q1 -- $1.3B $2.68 -- --
02/01/2022 Q4 -- $1.2B $2.47 -- --
11/02/2021 Q3 -- $1B $2.38 -- --
08/02/2021 Q2 -- $949M $2.27 -- --
05/04/2021 Q1 -- $829.2M $0.87 -- --
02/02/2021 Q4 -- $816.4M $0.90 -- --
11/03/2020 Q3 -- $795M $1.11 -- --
07/29/2020 Q2 -- $627.4M $0.61 -- --
05/05/2020 Q1 -- $701.4M $0.07 -- --
01/30/2020 Q4 -- $717.4M -$0.22 -- --
10/31/2019 Q3 -- $787.6M $0.62 -- --
07/30/2019 Q2 -- $771.5M $0.92 -- --
05/02/2019 Q1 -- $711.8M $0.18 -- --
01/30/2019 Q4 -- $774.3M $0.57 -- --
11/01/2018 Q3 -- $826.2M $1.52 -- --
07/31/2018 Q2 -- $793.4M $0.05 -- --
05/10/2018 Q1 -- $700M $0.37 -- --
01/31/2018 Q4 -- $710.7M $1.37 -- --
11/03/2017 Q3 -- $744.3M $0.56 -- --
07/28/2017 Q2 -- $720.4M $0.60 -- --
05/04/2017 Q1 -- $651.1M -$0.29 -- --
02/08/2017 Q4 -- $688.2M $0.06 -- --
11/03/2016 Q3 -- $713.9M $0.49 -- --
07/29/2016 Q2 -- $676.6M $0.39 -- --
04/29/2016 Q1 -- $621.5M -$0.24 -- --
02/03/2016 Q4 -- $648.1M $0.19 -- --

ArcBest Corp. Earnings Questions

  • How Much did ArcBest Corp. Generate in Revenue Last Quarter?

    ArcBest Corp. reported $1B worth of top line sales in its most recent quarter.

  • Did ArcBest Corp. Beat Earnings Last Quarter?

    ArcBest Corp. announced earnings per share of $1.72 which represents a beat of analyst forecast a $1.37 per share.

  • Is ArcBest Corp. Profitable?

    ArcBest Corp. reported $86.1M that represents $3.77 per share over the last quarter.

  • What is the Analyst Consensus for ArcBest Corp. EPS Next Year?

    ArcBest Corp.'s earnings are forecast to decrease from $7.28 per share to $6.01 per share next year representing a decrease of -48.62%.

  • When is ArcBest Corp.'s Earnings Date?

    ArcBest Corp.'s next earnings date is January 30, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock